Hyperthermia inhibited cellular function and induced immunogenic cell death of renal cell carcinoma

Author:

Huaqi Yin1,Bingqi Dong1,Yanhui Zhao2,Yongkang Ma1,Shiming Zhao1,Zhenghui Sun1,Zheng Du1,Jiangshan Peng1,Tiejun Yang1

Affiliation:

1. The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital

2. Qingdao Central Hospital

Abstract

Abstract Background: As a novel strategy, hyperthermia has been widely applied to cancer treatment recent years for its multiple anti-tumor effects. Especially, the potential influences of hyperthermia on tumor immune microenvironment may contribute to improve the efficacy of immunotherapy. However, the role of hyperthermia on renal cell carcinoma (RCC) is not well understood until now. Methods: In present study, we primarily evaluated the effects of hyperthermia on cellular function via cellular proliferation, migration assay, invasion and apoptosis assays. In addition, the influence of hyperthermia on immunogenicity of RCC cells were analyzed using flow cytometry analysis, enzyme-linked immunosorbent assays and IF staining. Results: our results showed that hyperthermia could significantly inhibit the proliferation, migration and invasion of RCC cells, and promote cell apoptosis. In addition, hyperthermia was verified to improve the immunogenicity of RCC cells via inducing immunogenic cell death. Conclusion: Our data demonstrated that hyperthermia was expected to be a promising therapeutic strategy for RCC.

Publisher

Research Square Platform LLC

Reference20 articles.

1. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives;Golovastova MO;CURR UROL REP,2017

2. Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects;Huaqi Y;MOL CANCER THER,2019

3. Kim MC, Jin Z, Kolb R, Borcherding N, Chatzkel JA, Falzarano SM, Zhang W. Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma. Cancers (Basel) 2021, 13(22).

4. Ballesteros PA, Chamorro J, Roman-Gil MS, Pozas J, Gomez DSV, Granados AR, Grande E, Alonso-Gordoa T, Molina-Cerrillo J. Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2021, 13(23).

5. Buonerba C, Dolce P, Iaccarino S, Scafuri L, Verde A, Costabile F, Pagliuca M, Morra R, Riccio V, Ribera D et al. Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.Cancers (Basel)2020, 12(2).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3